Registration Dossier

Toxicological information

Acute Toxicity: dermal

Currently viewing:

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: Only short abstract available and original reference not translated (czech)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1989
Report date:
1989

Materials and methods

Principles of method if other than guideline:
Rats were applied dermally with the test substance and observed for 14 days.
GLP compliance:
not specified
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
3,3'-[(2-chloro-5-methyl-p-phenylene)bis[imino(1-acetyl-2-oxoethylene)azo]]bis[4-chloro-N-(3-chloro-o-tolyl)benzamide]
EC Number:
226-970-7
EC Name:
3,3'-[(2-chloro-5-methyl-p-phenylene)bis[imino(1-acetyl-2-oxoethylene)azo]]bis[4-chloro-N-(3-chloro-o-tolyl)benzamide]
Cas Number:
5580-57-4
Molecular formula:
C43H35Cl5N8O6
IUPAC Name:
4-chloro-N-(3-chloro-2-methylphenyl)-3-[(E)-2-{1-[(5-chloro-4-{2-[(E)-2-{2-chloro-5-[(3-chloro-2-methylphenyl)carbamoyl]phenyl}diazen-1-yl]-3-oxobutanamido}-2-methylphenyl)carbamoyl]-2-oxopropyl}diazen-1-yl]benzamide
Test material form:
solid

Test animals

Species:
rat
Strain:
Wistar
Sex:
male
Details on test animals or test system and environmental conditions:
- Weight at study initiation: 245-303 g

Administration / exposure

Type of coverage:
not specified
Vehicle:
olive oil
Duration of exposure:
no data
Doses:
5000 mg/kg bw
No. of animals per sex per dose:
3
Control animals:
not required
Details on study design:
- Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes

Results and discussion

Effect levels
Key result
Sex:
male
Dose descriptor:
LD50
Effect level:
> 5 000 mg/kg bw
Based on:
test mat.
Remarks on result:
other: No mortalities observed.
Mortality:
No mortalities occured during observation period.
Clinical signs:
No clinical signs observed.
Gross pathology:
No macroscopic abnormalities observed.

Applicant's summary and conclusion